Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisEureka AI Inside
Professional Services
Customer Stories
Blog
Global Innovation Report
Glossary
Newsroom
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How neuromorphic computing architecture cuts energy in always-on sensor processing: event-driven SNNs, sparsity exploitation, in-memory compute, and 2000× power savings explained.
Article | Report Survey of non-opioid CLBP drug pipeline: anti-NGF antibodies, centralized pain mechanisms, dual-target biologics, and emerging nucleic acid approaches. Patent intelligence from PatSnap.
Article | Report How to improve TIM performance between power dies and heat spreaders in AI server modules — patent-backed strategies from Intel, Google, Tesla, IBM and more.
Article | Report How to improve TIM performance between power dies and heat spreaders in AI server modules — patent strategies from Intel, Google, Tesla, IBM, and Laird.
Article | Report Explore the OSA drug pipeline: hypoglossal nerve stimulation, GLP-1 receptor agonists, NRI combinations, and arousal threshold approaches reshaping sleep apnea treatment.
Article | Report Engineering a 10GW offshore wind HVDC transmission system: converter topology, MVDC collection grids, black-start capability, and submarine cable corridor planning examined through patent data.
Article | Report Explore the AF drug pipeline: rhythm control agents, novel antiarrhythmics, gene therapy, and precision pharmacology shaping atrial fibrillation treatment.
Article | Report How AI, Bayesian optimization, LLMs, and robotics are accelerating electrolyte formulation discovery for next-generation lithium batteries. Patent analysis by PatSnap.
Article | Report Myosin inhibitors, gene therapy, and RNA-targeting strategies are reshaping the non-obstructive HCM drug pipeline. Explore the patent signals and clinical evidence.
Article | Report DBC vs AMB substrates for SiC power modules: compare bonding chemistry, CTE mismatch, thermal conductivity, and reliability data from 50+ patent sources.
Article | Report Kallikrein inhibitors, Factor XIIa antibodies, RNAi, ASOs, and gene therapy for HAE prophylaxis: a patent-driven pipeline analysis from PatSnap Insights.
Article | Report Why ruthenium is replacing copper in sub-10nm BEOL interconnects: the material physics, structural innovations, and patent evidence from TSMC, Samsung, IBM, and Applied Materials.
Article | Report Budesonide, NorUDCA, and FMT lead the microscopic colitis drug pipeline. Explore the evidence on bile acid, microbiome, and glucocorticoid approaches for CC and LC.
Article | Report How do FinFET and nanosheet transistors differ in leakage current at cryogenic temperatures? A patent and literature analysis covering DIBL, freeze-out, BTBT, and substrate leakage.
Article | Report Budesonide, NorUDCA, and FMT are reshaping the microscopic colitis drug pipeline. Explore the latest evidence on three therapeutic approaches targeting CC and LC.